Skip to main content
Top
Published in: Head and Neck Pathology 1/2019

01-03-2019 | Special Issue: Colors and Textures, a Review of Oral Mucosal Entities

Ulcerated Lesions of the Oral Mucosa: Clinical and Histologic Review

Authors: Sarah G. Fitzpatrick, Donald M. Cohen, Ashley N. Clark

Published in: Head and Neck Pathology | Issue 1/2019

Login to get access

Abstract

Ulcerated lesions of the oral cavity have many underlying etiologic factors, most commonly infection, immune related, traumatic, or neoplastic. A detailed patient history is critical in assessing ulcerative oral lesions and should include a complete medical and medication history; whether an inciting or triggering trauma, condition, or medication can be identified; the length of time the lesion has been present; the frequency of episodes in recurrent cases; the presence or absence of pain; and the growth of the lesion over time. For multiple or recurrent lesions the presence or history of ulcers on the skin, genital areas, or eyes should be evaluated along with any accompanying systemic symptoms such as fever, arthritis, or other signs of underlying systemic disease. Biopsy may be indicated in many ulcerative lesions of the oral cavity although some are more suitable for clinical diagnosis. Neoplastic ulcerated lesions are notorious in the oral cavity for their ability to mimic benign ulcerative lesions, highlighting the essential nature of biopsy to establish a diagnosis in cases that are not clinically identifiable or do not respond as expected to treatment. Adjunctive tests may be required for final diagnosis of some ulcerated lesions especially autoimmune lesions. Laboratory tests or evaluation to rule out systemic disease may be also required for recurrent or severe ulcerations especially when accompanied by other symptoms. This discussion will describe the clinical and histopathologic characteristics of a variety of ulcerated lesions found in the oral cavity.
Literature
1.
2.
go back to reference Alam F, Argiriadou AS, Hodgson TA, et al. Primary syphilis remains a cause of oral ulceration. Br Dent J. 2000;189:352–4.PubMedCrossRef Alam F, Argiriadou AS, Hodgson TA, et al. Primary syphilis remains a cause of oral ulceration. Br Dent J. 2000;189:352–4.PubMedCrossRef
3.
5.
go back to reference Krawiecka E, Szponar E. Tuberculosis of the oral cavity: an uncommon but still a live issue. Adv Dermatol Allergol. 2015;32(4):302–6.CrossRef Krawiecka E, Szponar E. Tuberculosis of the oral cavity: an uncommon but still a live issue. Adv Dermatol Allergol. 2015;32(4):302–6.CrossRef
6.
go back to reference Yepes JF, Sullivan J, Pinto A. Tuberculosis: medical management update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:267–73.PubMedCrossRef Yepes JF, Sullivan J, Pinto A. Tuberculosis: medical management update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:267–73.PubMedCrossRef
7.
8.
go back to reference Clarkson E, Mashkoor F, Abdulateef S. Oral viral infections: diagnosis and management. Dent Clin N Am. 2017;61:351–63.PubMedCrossRef Clarkson E, Mashkoor F, Abdulateef S. Oral viral infections: diagnosis and management. Dent Clin N Am. 2017;61:351–63.PubMedCrossRef
9.
go back to reference Kolokotronis A, Doumas S. Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin Microbiol Infect. 2006;12:202–11.PubMedCrossRef Kolokotronis A, Doumas S. Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin Microbiol Infect. 2006;12:202–11.PubMedCrossRef
10.
go back to reference Baringer JR, Swoveland P. Recovery of herpes simplex virus from human trigeminal ganglions. N Engl J Med. 1973;288:648–50.PubMedCrossRef Baringer JR, Swoveland P. Recovery of herpes simplex virus from human trigeminal ganglions. N Engl J Med. 1973;288:648–50.PubMedCrossRef
11.
go back to reference Weathers DR, Griffin JW. Intraoral ulceratipons of recurrent herpes simplex and recurrent aphthae: two distinct clinical entities. J Am Dent Assoc. 1970;81:81–8.PubMedCrossRef Weathers DR, Griffin JW. Intraoral ulceratipons of recurrent herpes simplex and recurrent aphthae: two distinct clinical entities. J Am Dent Assoc. 1970;81:81–8.PubMedCrossRef
12.
go back to reference Cohen SG, Greenberg MS. Chronic oral herpes simplex virus infection in immunocompromised patients. Oral Surg Oral Med Oral Pathol. 1985;59:465–71.PubMedCrossRef Cohen SG, Greenberg MS. Chronic oral herpes simplex virus infection in immunocompromised patients. Oral Surg Oral Med Oral Pathol. 1985;59:465–71.PubMedCrossRef
13.
go back to reference Amir J. Clinical aspects and antiviral therapy in primary herpetic gingivostomatitis. Paediatr Drugs. 2001;3:593–7.PubMedCrossRef Amir J. Clinical aspects and antiviral therapy in primary herpetic gingivostomatitis. Paediatr Drugs. 2001;3:593–7.PubMedCrossRef
14.
go back to reference Arduino PG, Porder SR. Oral and perioral herpes simples virus type 1 (HSV-1) infection: review of its management. Oral Dis. 2006;12:254–70.PubMedCrossRef Arduino PG, Porder SR. Oral and perioral herpes simples virus type 1 (HSV-1) infection: review of its management. Oral Dis. 2006;12:254–70.PubMedCrossRef
15.
go back to reference Jensen LA, Hoehns JD, Squires CL. Oral antivirals for the acute treatment of recurrent herpes labialis. Ann Pharmacother. 2004;38:705–9.PubMedCrossRef Jensen LA, Hoehns JD, Squires CL. Oral antivirals for the acute treatment of recurrent herpes labialis. Ann Pharmacother. 2004;38:705–9.PubMedCrossRef
16.
go back to reference Woo SB, Challacombe SJ. Management of recurrent oral herpes simplex infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:12–8.CrossRef Woo SB, Challacombe SJ. Management of recurrent oral herpes simplex infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:12–8.CrossRef
18.
go back to reference Badger GR. Oral signs of chickenpox (varicella): report of two cases. J Dent Child. 1980;47:349–51. Badger GR. Oral signs of chickenpox (varicella): report of two cases. J Dent Child. 1980;47:349–51.
19.
go back to reference Kolokotronis A, Louloudiadis K, Fotiou G, et al. Oral manifestations of infections due to varicella zoster virus in otherwise healthy children. J Clin Pediatr Dent. 2001;25:107–12.PubMedCrossRef Kolokotronis A, Louloudiadis K, Fotiou G, et al. Oral manifestations of infections due to varicella zoster virus in otherwise healthy children. J Clin Pediatr Dent. 2001;25:107–12.PubMedCrossRef
20.
go back to reference Carmichael JK. Treatment of herpes zoster and postherpetic neuralgia. Am Fam Physician. 1991;44:203–10.PubMed Carmichael JK. Treatment of herpes zoster and postherpetic neuralgia. Am Fam Physician. 1991;44:203–10.PubMed
21.
go back to reference Tidwell E, Hutson B, Burkhart N, et al. Herpes zoster of the trigeminal nerve third branch: a case report and review of the literature. Int Endod J. 1999;32:61–6.PubMedCrossRef Tidwell E, Hutson B, Burkhart N, et al. Herpes zoster of the trigeminal nerve third branch: a case report and review of the literature. Int Endod J. 1999;32:61–6.PubMedCrossRef
22.
go back to reference Verbin RS, Heineman HS, Stiff RH. Localized odontalgia occurring during herpes zoster of the maxillary division of the fifth cranial nerve. Report of a case. Oral Surg Oral Med Oral Pathol. 1968;26:441–5.PubMedCrossRef Verbin RS, Heineman HS, Stiff RH. Localized odontalgia occurring during herpes zoster of the maxillary division of the fifth cranial nerve. Report of a case. Oral Surg Oral Med Oral Pathol. 1968;26:441–5.PubMedCrossRef
23.
go back to reference Wood M. Understanding Pain in Herpes Zoster: An Essential for Optimizing Treatment. J Infect Dis. 2002;186:78–82.CrossRef Wood M. Understanding Pain in Herpes Zoster: An Essential for Optimizing Treatment. J Infect Dis. 2002;186:78–82.CrossRef
24.
go back to reference Straus SE, Ostrove JM, Inchauspe G, et al. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment and prevention. Ann Intern Med. 1988;108:221–37.CrossRef Straus SE, Ostrove JM, Inchauspe G, et al. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment and prevention. Ann Intern Med. 1988;108:221–37.CrossRef
25.
go back to reference Stankus SJ, Dlugopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician. 2000;61:2437–48.PubMed Stankus SJ, Dlugopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician. 2000;61:2437–48.PubMed
26.
go back to reference Wutzler P. Antiviral therapy of herpes simplex and varicella-zoster virus infections. Intervirology. 1997;40:343–56.PubMedCrossRef Wutzler P. Antiviral therapy of herpes simplex and varicella-zoster virus infections. Intervirology. 1997;40:343–56.PubMedCrossRef
28.
go back to reference Dioguardi M, Troiano G, Russo LL, et al. Occult co-infection in the oral cavity with cytomegalovirus during immuno-suppression. J Transl Sci. 2015;1(2):26–8. Dioguardi M, Troiano G, Russo LL, et al. Occult co-infection in the oral cavity with cytomegalovirus during immuno-suppression. J Transl Sci. 2015;1(2):26–8.
29.
go back to reference Jones AC, Freedman PD, Phelan JA, et al. Cytomegalovirus infections of the oral cavity: a report of six cases and review of the literature. Oral Surf Oral Med Oral Pathol. 1993;75:76–85.CrossRef Jones AC, Freedman PD, Phelan JA, et al. Cytomegalovirus infections of the oral cavity: a report of six cases and review of the literature. Oral Surf Oral Med Oral Pathol. 1993;75:76–85.CrossRef
30.
go back to reference Sharland M, Khare MD. Cytomegalovirus treatment options in immunocompromised patients. Expert Opin Pharmacother. 2001;2(8):1247–57.PubMedCrossRef Sharland M, Khare MD. Cytomegalovirus treatment options in immunocompromised patients. Expert Opin Pharmacother. 2001;2(8):1247–57.PubMedCrossRef
31.
go back to reference Lakshman P, Samaranayake P, Keung Leung W, et al. Oral mucosal fungal infections. Periodontol 2000. 2009;49:39–59.CrossRef Lakshman P, Samaranayake P, Keung Leung W, et al. Oral mucosal fungal infections. Periodontol 2000. 2009;49:39–59.CrossRef
32.
go back to reference Napoli AJ, Donegan JO. Aspergillosis and necrosis of the maxilla: a case report. J Oral Maxillofac Surg. 1991;49:532–4.PubMedCrossRef Napoli AJ, Donegan JO. Aspergillosis and necrosis of the maxilla: a case report. J Oral Maxillofac Surg. 1991;49:532–4.PubMedCrossRef
33.
go back to reference Bell WA, Gamble J, Garrington GE. North American blastomycosis with oral lesions. Oral Surg Oral Med Oral Pathol. 1969;28:914–23.PubMedCrossRef Bell WA, Gamble J, Garrington GE. North American blastomycosis with oral lesions. Oral Surg Oral Med Oral Pathol. 1969;28:914–23.PubMedCrossRef
34.
go back to reference Page LR, Drummond JF, Daniels HT, et al. Blastomycosis with oral lesions. Report of two cases. Oral Surg Oral Med Oral Pathol. 1979;47:157–60.PubMedCrossRef Page LR, Drummond JF, Daniels HT, et al. Blastomycosis with oral lesions. Report of two cases. Oral Surg Oral Med Oral Pathol. 1979;47:157–60.PubMedCrossRef
35.
go back to reference Ferreira OG, Cardoso SV, Borges AS, et al. Oral histoplasmosis in Brazil. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(6):654–9.PubMedCrossRef Ferreira OG, Cardoso SV, Borges AS, et al. Oral histoplasmosis in Brazil. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(6):654–9.PubMedCrossRef
36.
go back to reference Rodriguez RA, Konuia T. Coccidioidomycosis of the tongue. Arch Pathol Lab Med. 2005;129:4–6. Rodriguez RA, Konuia T. Coccidioidomycosis of the tongue. Arch Pathol Lab Med. 2005;129:4–6.
37.
go back to reference Hay RJ. Overview of the treatment of disseminated fungal infections. J Antimicrob Chemother. 1991;28:17–25.PubMedCrossRef Hay RJ. Overview of the treatment of disseminated fungal infections. J Antimicrob Chemother. 1991;28:17–25.PubMedCrossRef
38.
go back to reference Lortholary O, Denning DW, Dupont B. Endemic mycoses: a treatment update. J Antimicrob Chemother. 1999;43:321–31.PubMedCrossRef Lortholary O, Denning DW, Dupont B. Endemic mycoses: a treatment update. J Antimicrob Chemother. 1999;43:321–31.PubMedCrossRef
39.
go back to reference Shah K, Guarderas J, Krishnaswamy G. Aphthous stomatitis. Ann Allergy Asthma Immunol. 2016;117:e341–3.CrossRef Shah K, Guarderas J, Krishnaswamy G. Aphthous stomatitis. Ann Allergy Asthma Immunol. 2016;117:e341–3.CrossRef
40.
go back to reference Shim YJ, Choi JH, Ahn HJ, Kwon JS. Effect of sodium lauryl sulfate on recurrent aphthous stomatitis: a randomized controlled clinical trial. Oral Dis. 2012;18(7):655–60.PubMedCrossRef Shim YJ, Choi JH, Ahn HJ, Kwon JS. Effect of sodium lauryl sulfate on recurrent aphthous stomatitis: a randomized controlled clinical trial. Oral Dis. 2012;18(7):655–60.PubMedCrossRef
41.
go back to reference Gomes CC, Gomez RS, Zina LG, Amaral FR. Recurrent aphthous stomatitis and Helicobacter pylori. Med Oral Patol Oral Cir Bucal. 2016;21(2):e187-91.PubMed Gomes CC, Gomez RS, Zina LG, Amaral FR. Recurrent aphthous stomatitis and Helicobacter pylori. Med Oral Patol Oral Cir Bucal. 2016;21(2):e187-91.PubMed
42.
go back to reference Miziara ID, Auaujo-Filho BC, Weber R. AIDS and recurrent aphthous stomatitis. Rev Bras Otorhinolaringol. 2005;71(4):517–20.CrossRef Miziara ID, Auaujo-Filho BC, Weber R. AIDS and recurrent aphthous stomatitis. Rev Bras Otorhinolaringol. 2005;71(4):517–20.CrossRef
43.
go back to reference Tan CXW, Brand HS, de Boer NKH, Forouzanfar T. Gastrointestinal diseases and their oro-dental manifestations: part 1: Crohn’s disease. Br Dent J. 2016;221(12):794–9.PubMedCrossRef Tan CXW, Brand HS, de Boer NKH, Forouzanfar T. Gastrointestinal diseases and their oro-dental manifestations: part 1: Crohn’s disease. Br Dent J. 2016;221(12):794–9.PubMedCrossRef
44.
go back to reference Tan CXW, Brand HS, de Boer NKH, Forouzanfar T. Gastrointestinal diseases and their oro-dental manifestations: part 2: Ulcerative colitis. Br Dent J. 2017;222(1):53–7.PubMedCrossRef Tan CXW, Brand HS, de Boer NKH, Forouzanfar T. Gastrointestinal diseases and their oro-dental manifestations: part 2: Ulcerative colitis. Br Dent J. 2017;222(1):53–7.PubMedCrossRef
45.
go back to reference Macho VMP, Coelho AS, Veloso e Silva DM, de Andrade DJC. Oral manifestations in pediatric patients with coeliac disease: a review article. Open Dent J. 2017;11:539–45.PubMedPubMedCentralCrossRef Macho VMP, Coelho AS, Veloso e Silva DM, de Andrade DJC. Oral manifestations in pediatric patients with coeliac disease: a review article. Open Dent J. 2017;11:539–45.PubMedPubMedCentralCrossRef
46.
go back to reference Cantekin K, Arslan D, Delikan E. Presence and distribution of dental enamel defects, recurrent aphthous lesions and dental caries in children with celiac disease. Pak J Med Sci. 2015;31(3):606–9.PubMedPubMedCentral Cantekin K, Arslan D, Delikan E. Presence and distribution of dental enamel defects, recurrent aphthous lesions and dental caries in children with celiac disease. Pak J Med Sci. 2015;31(3):606–9.PubMedPubMedCentral
48.
go back to reference Pak S, Logemann S, Dee C, Fershko A. Breaking the magic: mouth and genital ulcers with inflamed cartilage syndrome. Cureus. 2017;9(10):e1743.PubMedPubMedCentral Pak S, Logemann S, Dee C, Fershko A. Breaking the magic: mouth and genital ulcers with inflamed cartilage syndrome. Cureus. 2017;9(10):e1743.PubMedPubMedCentral
49.
go back to reference Wu D, Xin J, Liu J, Zhou P. The association between interleukin polymorphism and recurrent aphthous stomatitis: a meta-analysis. Arch Oral Biol. 2018;93:3–11.PubMedCrossRef Wu D, Xin J, Liu J, Zhou P. The association between interleukin polymorphism and recurrent aphthous stomatitis: a meta-analysis. Arch Oral Biol. 2018;93:3–11.PubMedCrossRef
50.
go back to reference Vitale A, Orlando I, Lopalco G, Emmi G, Cattalini M, Frediani B, Galeazzi M, Iannone F, Rigante D, Cantarini L. Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndrome. Clin Exp Rheumatol. 2016;34(6 Suppl 102):77–81.PubMed Vitale A, Orlando I, Lopalco G, Emmi G, Cattalini M, Frediani B, Galeazzi M, Iannone F, Rigante D, Cantarini L. Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndrome. Clin Exp Rheumatol. 2016;34(6 Suppl 102):77–81.PubMed
51.
go back to reference Scully C, MacFadyen E, Campbell A. Oral manifestations in cyclic neutropenia. Br J Oral Surg. 1982;20(2):96–101.PubMedCrossRef Scully C, MacFadyen E, Campbell A. Oral manifestations in cyclic neutropenia. Br J Oral Surg. 1982;20(2):96–101.PubMedCrossRef
52.
go back to reference Femiano F, Gombos F, Scully C. Sweet’s syndrome: recurrent oral ulceration, pyrexia, thrombophlebitis, and cutaneous lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:324–7.PubMedCrossRef Femiano F, Gombos F, Scully C. Sweet’s syndrome: recurrent oral ulceration, pyrexia, thrombophlebitis, and cutaneous lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:324–7.PubMedCrossRef
53.
54.
go back to reference Maderal AD, Salisbury PL, Jorizzo JL. Desquamative gingivitis: clinical findings and diseases. J Am Acad Dermatol. 2018;78:839–48.PubMedCrossRef Maderal AD, Salisbury PL, Jorizzo JL. Desquamative gingivitis: clinical findings and diseases. J Am Acad Dermatol. 2018;78:839–48.PubMedCrossRef
55.
go back to reference Yuan A, Woo S-B. Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:35–47.PubMedCrossRef Yuan A, Woo S-B. Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:35–47.PubMedCrossRef
56.
go back to reference Celentano A, Tovaru S, Yap T, Adamo D, Aria M, Mignogna MD. Oral erythema multiforme: trends and clinical findings of a large retrospective European case series. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:707–16.PubMedCrossRef Celentano A, Tovaru S, Yap T, Adamo D, Aria M, Mignogna MD. Oral erythema multiforme: trends and clinical findings of a large retrospective European case series. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:707–16.PubMedCrossRef
57.
go back to reference Heinze A, Tollefson M, Holland KE. Chiu YE. Characteristics of pediatric recurrent erythema multiforme. Pediatr Dermatol. 2018;35:97–103.PubMedCrossRef Heinze A, Tollefson M, Holland KE. Chiu YE. Characteristics of pediatric recurrent erythema multiforme. Pediatr Dermatol. 2018;35:97–103.PubMedCrossRef
58.
60.
go back to reference Müller S. Oral lichenoid lesions: distinguishing the benign from the deadly. Mod Pathol. 2017;30:54–67.CrossRef Müller S. Oral lichenoid lesions: distinguishing the benign from the deadly. Mod Pathol. 2017;30:54–67.CrossRef
61.
go back to reference Cheng YS, Gould A, Kurago Z, Fantasia J, Müller S. Diagnosis of oral lichen planus: a position paper of the American academy of oral and maxillofacial pathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(3):332–54.PubMedCrossRef Cheng YS, Gould A, Kurago Z, Fantasia J, Müller S. Diagnosis of oral lichen planus: a position paper of the American academy of oral and maxillofacial pathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(3):332–54.PubMedCrossRef
62.
go back to reference Alaizari NA, Al-Maweri SA, Al-Shamiri HM, Shugaa-Addin B. Hepatitis C virus infections in oral lichen planus: a systematic review and meta-analysis. Aust Dent J. 2016;61:282–7.PubMedCrossRef Alaizari NA, Al-Maweri SA, Al-Shamiri HM, Shugaa-Addin B. Hepatitis C virus infections in oral lichen planus: a systematic review and meta-analysis. Aust Dent J. 2016;61:282–7.PubMedCrossRef
63.
go back to reference Fortuna G, Massimo A, Schiavo JH. Drug-induced oral lichenoid reactions: a real clinical entity? A systematic review. Eur J Clin Pharmacol. 2017;73:1523–37.PubMedCrossRef Fortuna G, Massimo A, Schiavo JH. Drug-induced oral lichenoid reactions: a real clinical entity? A systematic review. Eur J Clin Pharmacol. 2017;73:1523–37.PubMedCrossRef
64.
go back to reference Fitzpatrick SG, Honda KS, Sattar A, Hirsch SA. Histologic lichenoid features in oral dysplasia and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(4):511–20.PubMedCrossRef Fitzpatrick SG, Honda KS, Sattar A, Hirsch SA. Histologic lichenoid features in oral dysplasia and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(4):511–20.PubMedCrossRef
65.
go back to reference Montague LM, Bhattacharyya I, Islam NM, Cohen DM, Fitzpatrick SG. Direct immunofluorescence testing results in cases of premalignant and malignant oral lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(6):675–83.PubMedCrossRef Montague LM, Bhattacharyya I, Islam NM, Cohen DM, Fitzpatrick SG. Direct immunofluorescence testing results in cases of premalignant and malignant oral lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(6):675–83.PubMedCrossRef
66.
go back to reference Yamanaka Y, Yamashita M, Innocentini LMA, Macedo LD, Chahud F, Ribeiro-Silva A, Roselino AM, Rocha MJA, Motta AC. Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions. Am J Dermatopathol. 2018;40:491–7.PubMedCrossRef Yamanaka Y, Yamashita M, Innocentini LMA, Macedo LD, Chahud F, Ribeiro-Silva A, Roselino AM, Rocha MJA, Motta AC. Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions. Am J Dermatopathol. 2018;40:491–7.PubMedCrossRef
67.
go back to reference Jajarm HH, Asadi R, Bardideh E, Shafaee H, Khazaei Y, Emadzadeh M. The effects of photodynamic and low-level laser therapy for treatment of oral lichen planus—a systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2018;23:254–60.CrossRef Jajarm HH, Asadi R, Bardideh E, Shafaee H, Khazaei Y, Emadzadeh M. The effects of photodynamic and low-level laser therapy for treatment of oral lichen planus—a systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2018;23:254–60.CrossRef
68.
go back to reference Gupta S, Gosh S, Gupta S. Interventions for the management of oral lichen planus: a review of the conventional and novel therapies. Oral Dis. 2017;23:1029–42.PubMedCrossRef Gupta S, Gosh S, Gupta S. Interventions for the management of oral lichen planus: a review of the conventional and novel therapies. Oral Dis. 2017;23:1029–42.PubMedCrossRef
70.
go back to reference Kridin K. Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations. Immunol Res. 2018;66:6–17.PubMedCrossRef Kridin K. Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations. Immunol Res. 2018;66:6–17.PubMedCrossRef
71.
go back to reference Ohki M, Kikuchi S. Nasal, oral, and pharyngolaryngeal manifestations of pemphigus vulgaris: endoscopic ororhinolaryngologic examination. Ear Nose Throat J. 2017;96(3):120–7.PubMedCrossRef Ohki M, Kikuchi S. Nasal, oral, and pharyngolaryngeal manifestations of pemphigus vulgaris: endoscopic ororhinolaryngologic examination. Ear Nose Throat J. 2017;96(3):120–7.PubMedCrossRef
73.
go back to reference Hong GH, Khan IR, Shifera AS, Okeagu C, Thorne JE. Incidence and clinical characteristics of ocular involvement in mucous membrane pemphigoid. Ocul Immunol Inflamm. 2018;19:1–5.CrossRef Hong GH, Khan IR, Shifera AS, Okeagu C, Thorne JE. Incidence and clinical characteristics of ocular involvement in mucous membrane pemphigoid. Ocul Immunol Inflamm. 2018;19:1–5.CrossRef
74.
go back to reference Bagan J, Jiménez Y, Murillo J, Bagan L. Oral mucous membrane pemphigoid: a clinical study of 100 low-risk cases. Oral Dis. 2018;24:132–4.PubMedCrossRef Bagan J, Jiménez Y, Murillo J, Bagan L. Oral mucous membrane pemphigoid: a clinical study of 100 low-risk cases. Oral Dis. 2018;24:132–4.PubMedCrossRef
75.
go back to reference Maderal AD, Salisbury P, Jorizzo JL. Desquamative gingivitis: diagnosis and treatment. J Am Acad Dermatol. 2018;78(5):851–61.PubMedCrossRef Maderal AD, Salisbury P, Jorizzo JL. Desquamative gingivitis: diagnosis and treatment. J Am Acad Dermatol. 2018;78(5):851–61.PubMedCrossRef
76.
go back to reference Di Zenzo G, Carrozza M, Chan LS. Urban legend series: mucous membrane pemphigoid. Oral Dis. 2014;20:35–54.PubMedCrossRef Di Zenzo G, Carrozza M, Chan LS. Urban legend series: mucous membrane pemphigoid. Oral Dis. 2014;20:35–54.PubMedCrossRef
77.
go back to reference Gilvetti C, Porter SR, Fedele S. Traumatic chemical oral ulceration: a case report and review of the literature. Br Dent J. 2010;208(7):297–300.PubMedCrossRef Gilvetti C, Porter SR, Fedele S. Traumatic chemical oral ulceration: a case report and review of the literature. Br Dent J. 2010;208(7):297–300.PubMedCrossRef
78.
go back to reference Kang S, Kufta K, Sollecito TP, Panchal N. A treatment algorithm for the management of intraoral burns: a narrative review. Burns. 2018;44:1065–76.PubMedCrossRef Kang S, Kufta K, Sollecito TP, Panchal N. A treatment algorithm for the management of intraoral burns: a narrative review. Burns. 2018;44:1065–76.PubMedCrossRef
79.
go back to reference Nahlieli O, Eliav E, Shapira Y, Baruchin AM. Central palatal burns associated with the eating of microwaved pizzas. Burns. 1999;25:465–6.PubMedCrossRef Nahlieli O, Eliav E, Shapira Y, Baruchin AM. Central palatal burns associated with the eating of microwaved pizzas. Burns. 1999;25:465–6.PubMedCrossRef
80.
go back to reference Harrison R, Hicklin D. Electronic cigarette explosions involving the oral cavity. J Am Dent Assoc. 2016;147(11):891–6.PubMedCrossRef Harrison R, Hicklin D. Electronic cigarette explosions involving the oral cavity. J Am Dent Assoc. 2016;147(11):891–6.PubMedCrossRef
81.
go back to reference Cowan D, Ho B, Sykes KJ, Wei JL. Pediatric oral burns: a ten-year review of patient characteristics, etiologies and treatment outcomes. Int J Pediatr Otorhinolaryngol. 2013;77:1325–8.PubMedCrossRef Cowan D, Ho B, Sykes KJ, Wei JL. Pediatric oral burns: a ten-year review of patient characteristics, etiologies and treatment outcomes. Int J Pediatr Otorhinolaryngol. 2013;77:1325–8.PubMedCrossRef
82.
go back to reference Jainkittivong A, Aneksuk V, Langlais RP. Oral mucosal lesions in denture wearers. Gerodontology. 2010;27:26–32.PubMedCrossRef Jainkittivong A, Aneksuk V, Langlais RP. Oral mucosal lesions in denture wearers. Gerodontology. 2010;27:26–32.PubMedCrossRef
83.
go back to reference Carlson DL. Necrotizing sialometaplasia: a practical approach to the diagnosis. Arch Pathol Lab Med. 2009;133(5):692–8.PubMed Carlson DL. Necrotizing sialometaplasia: a practical approach to the diagnosis. Arch Pathol Lab Med. 2009;133(5):692–8.PubMed
84.
go back to reference Butler JN, Kobayashi TT. Traumatic ulcerative granuloma with stromal eosinophilia: a malignant-appearing benign lesion. Cutis. 2017;100:E28–31.PubMed Butler JN, Kobayashi TT. Traumatic ulcerative granuloma with stromal eosinophilia: a malignant-appearing benign lesion. Cutis. 2017;100:E28–31.PubMed
85.
go back to reference Shen WR, Chang JY, Wu YC, Cheng SJ, Chen HM, Wang YP. Oral traumatic ulcerative granuloma with stromal eosinophilia: A clinicopathological study of 34 cases. J Formos Med Assoc. 2015;114(9):881–5.PubMedCrossRef Shen WR, Chang JY, Wu YC, Cheng SJ, Chen HM, Wang YP. Oral traumatic ulcerative granuloma with stromal eosinophilia: A clinicopathological study of 34 cases. J Formos Med Assoc. 2015;114(9):881–5.PubMedCrossRef
86.
go back to reference Hirschberg A, Amariglio N, Akrish S, Yahalom R, Rosenbaum H, Okon E, Kaplan I. Traumatic Ulcerative granuloma with stromal eosinophilia. A reactive lesion of the oral mucosa. Am J Clin Pathol. 2006;126:522–9.CrossRef Hirschberg A, Amariglio N, Akrish S, Yahalom R, Rosenbaum H, Okon E, Kaplan I. Traumatic Ulcerative granuloma with stromal eosinophilia. A reactive lesion of the oral mucosa. Am J Clin Pathol. 2006;126:522–9.CrossRef
87.
go back to reference Salisbury CL, Budnick SD, Li S. T-cell receptor gene rearrangement and CD30 immunoreactivity in traumatic ulcerative granuloma with stromal eosinophilia of the oral cavity. Am J Clin Pathol. 2009;132:722–7.PubMedCrossRef Salisbury CL, Budnick SD, Li S. T-cell receptor gene rearrangement and CD30 immunoreactivity in traumatic ulcerative granuloma with stromal eosinophilia of the oral cavity. Am J Clin Pathol. 2009;132:722–7.PubMedCrossRef
88.
go back to reference Yang EC, Tan MT, Schwarz RA, Richards-Kortum RR, Gillenwater AM, Vigneswaran N. Noninvasive diagnostic adjuncts for the evaluation of potentially premalignant oral epithelial lesions: current limitations and future directions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:670–81.PubMedPubMedCentralCrossRef Yang EC, Tan MT, Schwarz RA, Richards-Kortum RR, Gillenwater AM, Vigneswaran N. Noninvasive diagnostic adjuncts for the evaluation of potentially premalignant oral epithelial lesions: current limitations and future directions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:670–81.PubMedPubMedCentralCrossRef
89.
go back to reference Porter S, Gueiros LA, Leão JC, Fedele S. Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:603–11.PubMedCrossRef Porter S, Gueiros LA, Leão JC, Fedele S. Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:603–11.PubMedCrossRef
90.
go back to reference Nikitakis NG, Pentenero M, Georgaki M, Poh CF, Peterson DE, Edwards P, Lingen M, Sauk JJ. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:650–69.PubMedCrossRef Nikitakis NG, Pentenero M, Georgaki M, Poh CF, Peterson DE, Edwards P, Lingen M, Sauk JJ. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:650–69.PubMedCrossRef
91.
go back to reference Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, Graham FJ, Hujoel PP, Kalmar JR, Koch WM, Lambert PM, Lingen MW, Oettmeier BW Jr, Patton LL, Perkins D, Reid BC, Sciubba JJ, Tomar SL, Wyatt AD Jr, Aravamudhan K, Frantsye-Hawley J, Cleveland JL, Meyer DM. American dental association council on scientific affairs expert panel on screening for oral squamous cell carcinomas. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. JADA. 2010;141(5):509–20.PubMed Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, Graham FJ, Hujoel PP, Kalmar JR, Koch WM, Lambert PM, Lingen MW, Oettmeier BW Jr, Patton LL, Perkins D, Reid BC, Sciubba JJ, Tomar SL, Wyatt AD Jr, Aravamudhan K, Frantsye-Hawley J, Cleveland JL, Meyer DM. American dental association council on scientific affairs expert panel on screening for oral squamous cell carcinomas. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. JADA. 2010;141(5):509–20.PubMed
92.
go back to reference Awadallah M, Idle M, Patel K, Kademani D. Management update of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:628–36.PubMedCrossRef Awadallah M, Idle M, Patel K, Kademani D. Management update of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:628–36.PubMedCrossRef
93.
go back to reference Müller S. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:591–602.PubMedCrossRef Müller S. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:591–602.PubMedCrossRef
94.
go back to reference Francisconi CF, Caldas RJ, Oliveira Martins LJ, Fischer Rubira CM, da Silva Santos PS. Leukemic oral manifestations and their management. Asian Pac J Cancer Prev. 2016;17(3):911–5.PubMedCrossRef Francisconi CF, Caldas RJ, Oliveira Martins LJ, Fischer Rubira CM, da Silva Santos PS. Leukemic oral manifestations and their management. Asian Pac J Cancer Prev. 2016;17(3):911–5.PubMedCrossRef
96.
go back to reference Swerdlow SH, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. In: World Health Organization classification of tumours. Lyon: IARC; 2016. Swerdlow SH, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. In: World Health Organization classification of tumours. Lyon: IARC; 2016.
97.
go back to reference Al-Hakeem DA, Fedele S, Carlos R, Porter S. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol. 2007;43:4–14.PubMedCrossRef Al-Hakeem DA, Fedele S, Carlos R, Porter S. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol. 2007;43:4–14.PubMedCrossRef
98.
go back to reference Rodrigo JP, Suarez C, Rinaldo A, Devaney KO, Carbone A, Barnes L, Heffner DK, Ferlito A. Idiopathic midline destructive disease: fact or fiction. Oral Oncol. 2005;41:340–8.PubMedCrossRef Rodrigo JP, Suarez C, Rinaldo A, Devaney KO, Carbone A, Barnes L, Heffner DK, Ferlito A. Idiopathic midline destructive disease: fact or fiction. Oral Oncol. 2005;41:340–8.PubMedCrossRef
99.
go back to reference Dojcinov SD, Venkataraman MD, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer—a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34:405–17.PubMedCrossRefPubMedCentral Dojcinov SD, Venkataraman MD, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer—a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34:405–17.PubMedCrossRefPubMedCentral
100.
go back to reference Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent post-transplant lymphoproliferative disorder. Am J Surg Pathol. 2014;38:1522–9.PubMedCrossRef Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent post-transplant lymphoproliferative disorder. Am J Surg Pathol. 2014;38:1522–9.PubMedCrossRef
101.
go back to reference McCormack C, Huang Q. EBV1 mucocutaneous ulcer: a new entity of WHO 2017. Blood. 2018;131(17):1993.PubMedCrossRef McCormack C, Huang Q. EBV1 mucocutaneous ulcer: a new entity of WHO 2017. Blood. 2018;131(17):1993.PubMedCrossRef
Metadata
Title
Ulcerated Lesions of the Oral Mucosa: Clinical and Histologic Review
Authors
Sarah G. Fitzpatrick
Donald M. Cohen
Ashley N. Clark
Publication date
01-03-2019
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 1/2019
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-018-0981-8

Other articles of this Issue 1/2019

Head and Neck Pathology 1/2019 Go to the issue

Special Issue: Colors and Textures, a Review of Oral Mucosal Entities

Black and Brown Oro-facial Mucocutaneous Neoplasms

Special Issue: Colors and Textures, a Review of Oral Mucosal Entities

Erythematous and Vascular Oral Mucosal Lesions: A Clinicopathologic Review of Red Entities

Special Issue: Colors and Textures, a Review of Oral Mucosal Entities

Black and Brown: Non-neoplastic Pigmentation of the Oral Mucosa

Special Issue: Colors and Textures, a Review of Oral Mucosal Entities

Tongue Lumps and Bumps: Histopathological Dilemmas and Clues for Diagnosis

Special Issue: Colors and Textures, a Review of Oral Mucosal Entities

HPV-Related Papillary Lesions of the Oral Mucosa: A Review

Special Issue: Colors and Textures, a Review of Oral Mucosal Entities

A Rainbow of Colors and Spectrum of Textures: An Approach to Oral Mucosal Entities